key: cord-0426399-4erleqb9
authors: Jia, Xiaoxiao; Chua, Brendon Y; Loh, Liyen; Koutsakos, Marios; Kedzierski, Lukasz; Olshanski, Moshe; Heath, William R; Xu, Jianqing; Wang, Zhongfang; Kedzierska, Katherine
title: High expression of CD38 and MHC class II on CD8+ T cells during severe influenza disease reflects bystander activation and trogocytosis
date: 2021-02-09
journal: bioRxiv
DOI: 10.1101/2021.02.09.430410
sha: 9984445599e2e44c85c942c3cfc9af6a61398fb2
doc_id: 426399
cord_uid: 4erleqb9

Although co-expression of CD38 and HLA-DR on CD8+ T cells reflects activation during influenza, SARS-CoV-2, Dengue, Ebola and HIV-1 viral infections, high and prolonged CD38+HLA-DR+ expression can be associated with severe and fatal disease outcomes. As the expression of CD38+HLA-DR+ is poorly understood, we used mouse models of influenza A/H7N9, A/H3N2 and A/H1N1 infection to investigate the mechanisms underpinning CD38+MHC-II+ phenotype on CD8+ T-cells. Our analysis of influenza-specific immunodominant DbNP366+CD8+ T-cell responses showed that CD38+MHC-II+ co-expression was detected on both virus-specific and bystander CD8+ T-cells, with increased numbers of both CD38+MHC-II+CD8+ T-cell populations observed in the respiratory tract during severe infection. To understand the mechanisms underlying CD38 and MHC-II expression, we also used adoptively-transferred transgenic OT-I CD8+ T-cells recognising the ovalbumin-derived KbSIINFEKL epitope and A/H1N1-SIINKEKL infection. Strikingly, we found that OT-I cells adoptively-transferred into MHC-II−/− mice did not display MHC-II after influenza virus infection, suggesting that MHC-II was acquired via trogocytosis in wild-type mice. Additionally, detection of CD19 on CD38+MHC II+ OT-I cells further supports that MHC-II was acquired by trogocytosis, at least partially, sourced from B-cells. Our results also revealed that co-expression of CD38+MHC II+ on CD8+ T-cells was needed for the optimal recall ability following secondary viral challenge. Overall, our study provides evidence that both virus-specific and bystander CD38+MHC-II+ CD8+ T-cells are recruited to the site of infection during severe disease, and that MHC-II expression occurs via trogocytosis from antigen-presenting cells. Our findings also highlight the importance of the CD38+MHC II+ phenotype for CD8+ T-cell memory establishment and recall. Summary Co-expression of CD38 and MHC-II on CD8+ T cells is recognized as a classical hallmark of activation during viral infections. High and prolonged CD38+HLA-DR+ expression, however, can be associated with severe disease outcomes and the mechanisms are unclear. Using our established influenza wild-type and transgenic mouse models, we determined how disease severity affected the activation of influenza-specific CD38+MHC-II+CD8+ T cell responses in vivo and the antigenic determinants that drive their activation and expansion. Overall, our study provides evidence that both virus-specific and bystander CD38+MHC-II+ CD8+ T-cells are recruited to the site of infection during severe disease, and that MHC-II expression occurs, at least in part, via trogocytosis from antigen-presenting cells. Our findings also highlight the importance of the CD38+MHC II+ phenotype for CD8+ T-cell memory establishment and recall.

7 phenotype of CD38 + MHC-II + and CD38 + PD-1 + CD8 + T cells, we infected B6 mice intranasally with 157 a low (10 2 pfu) or high (10 5 pfu) dose of A/HK/x31 (H3N2; X31) virus ( Fig 3A) . While comparable 158 virus replication kinetics were observed at d3, d5, d7 and d10 after infection (Fig 3B) , the high dose 159 caused more severe disease, as evidenced by significantly greater body weight loss between d3 and 160 d7 (p<0.001) (Fig 3C) , and increased lethality (p=0.003) (Fig 3D) as well as excessive inflammation 161 in the lung (Fig 3E) . The 10 5 pfu X31 virus challenge was associated with more rapid acquisition of 162 a PD-1 hi phenotype (p<0.05 on d7) on D b NP366 + CD8 + T cells (Fig. 3F) , relecting the pattern found 163 previously for H7N9-infected mice and patients who succumbed to H7N9 disease. 164

Although cell numbers for all CD38 + MHC-II + and CD38 + PD-1 + CD8 + T cells in the regional 165 MLN were comparable from d5 and beyond (Fig 3H (i) ), only a small population of cells (11.8%) 166

were D b NP366 + (Fig 3H (ii) ) within CD38 + MHC-II + CD8 + T cells (peak d10) and (17.3%) within 167 CD38 + PD-1 + CD8 + T cells (peak d16), indicating that the majority of CD38 + MHC-II + and CD38 + PD-168 1 + CD8 + T cells recruited during severe influenza disease were tetramer-negative. Furthermore, 169 CD38 + MHC-II + and CD38 + PD-1 + CD8 + T cells were increased and peaked earlier (d7) at the site of 170 infection (BAL) following the high dose challenge (Fig 3H i left, Fig S2) , while the IAV-specific 171 CD8 + T cell responses peaked 3 days later (Fig 3H ii left, Fig S2) and at comparable numbers for 172 both (10 5 and 10 2 pfu) groups. Together, these data suggest that D b NP366 tetramer-negative 173 CD38 + MHC-II + CD8 + T-cells, many of which numerically will not be virus-specific, extravasate into 174 the lung prior to recruitment of the majority of antigen-specific cells. Whether this is a consequence 175 or a cause of more severe inflammation and pathology is currently unclear. 176 177 CD38 + CD8 + T cells utilise trogocytosis to acquire expression of MHC-II 178

As expression of the H2-Ab (MHC-II) gene at the transcriptional level depends on the 179 transcription factor CIITA[25] [26] , and murine CD8 + T cells lack intrinsically expressed CIITA [27] , 180 we further investigated how murine CD8 + T cells acquire expression of the MHC-II. We utilised a 8 for the K b OVA257-264 (OVA; SIINFEKL) epitope, which proliferate after infection with influenza-183 OVA virus (with SIINFEKL engineered into the neuraminidase stalk) 53 . We adoptively transferred 184 naïve OT-I CD8 + T cells into MHC II -/or C57BL/6 wild-type mice prior to X31-OVA infection (Fig  185   4A ). We observed greater body weight loss (5%) in MHC II -/mice compared to wild-type mice 186 particularly at 3-5 days post-infection (Fig 4B) , indicating that lack of MHC-II expression leads to 187 perturbed immune responses and increased disease severity. When we analysed the expansion of OT-188 I cells (Fig 4Ci) by frequency (Fig 4Cii) or number (Fig 4Ciii) of the total CD8 + T cell pool, we 189 observed similar numbers in BAL, MLNs and spleens of both WT and MHC II -/mice. As there were 190 also no differences in the combined total number of OT-I cells from these organs of each mouse (Fig 191 4C iv), this indicates that OT-I cells proliferate to the same extent in both WT and MHC-/-mice. 192

Analysis of MHC-II expression on OT-I cells in BAL, MLNs and spleens of MHC-II -/or B6 193 mice showed that MHC-II phenotype was only limited to OT-I cells transferred into B6 mice and 194 absent in those transferred into MHC-II -/mice (Fig 5Ai-iii) . This observation extended to CD38 + 195 OT-I cells, thus indicating that murine CD8 + T cells do not intrinsically express MHC-II but acquire 196 it from other cells during influenza virus infection. 197

To determine how transferred OT-I cells could have acquired MHC-II, we stained OT-I cells 198

in influenza-infected mice for markers associated with antigen presentation, including CD19 to 199 represent B cells and CD11c as a surrogate DC and macrophage marker [28] . In BAL, MLN and 200 spleen, CD11c + OT-I cells were consistently detected on both CD38 -MHC-II + and CD38 + MHC-II + 201 populations in the BAL (mean 11.7% and 31.4%) as well as the MLN (mean 20.5% vs 37.5%) and 202 10 CD38 + MHC-II + cells with OT-I numbers being ~3.1-fold and ~4.2-fold higher, respectively, when 234 compared to other subsets. 235

Given that we observed the acquisition of MHC-II molecules by CD8 + T cells during primary 236 infection (Fig 5) , we investigated whether this process also occurred following secondary challenge. 237

Irrespective of the original phenotype of OT-I cells transferred, MHC-II + OT-I cells (mean range 238 from 20.4-31.06% across four groups) were found in BAL (Fig 7D i,ii) . Furthermore, distinct 239 populations of CD38 + MHC-II + OT-I cells were detected in the spleens of mice across all four groups 240 ( Fig 7D i,iii) , indicating that OT-I cells that did not previously exhibit this phenotype can differentiate 241 into CD38 + MHC II + expressing cells upon rechallenge. This, however, did not improve their recall 242 ability and highlights the importance of establishing CD38 + MHC-II + phenotype prior to secondary 243 exposure. Interestingly, while both CD19 + and CD11c + OT-I cells could be found on CD38 + MHC II + 244 OT-I cells in the spleens of all animal groups (Fig 7E i,iii) , only CD19 -CD11c + OT-I cells could be 245 detected in BAL (Fig 7E i, Within the total primed CD38 + MHC-II + CD8 + T cell population in mice following influenza 271 virus infection, a large proportion appeared to be tetramer-negative, which indicates recruitment of 272 bystander CD8 + T cells at the site of infection. This was observed within populations of endogenous 273 primary CD38 + MHC-II + CD8 + T cell populations (Fig.3) and during the secondary recall of OT-I 274 cells (Fig.4) 

Mortality, 504 morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an 505 analysis for the Global Burden of Disease Study

Probable person-to-person transmission of avian influenza A (H5N1)

Defective CD8 T Cell Memory Following Acute Infection Without CD4

CD4-deficient mice 652 have reduced levels of memory cytotoxic T lymphocytes after immunization and show 653 diminished resistance to subsequent virus challenge

Acquisition of HLA-DR and Costimulatory Molecules by

T Cells from Allogeneic Antigen Presenting Cells

Antigen-659 specific T-T interactions regulate CD4 T-cell expansion

Internalization of Peptide-MHC Complexes Acquired by T Cells. Science (80-)

What is trogocytosis and what is its purpose?

Cutting Edge: CTLs Rapidly Capture 55

Signatures Delineate Transcriptional Programs during Virus-Specific CD8+ T Cell